Yahoo Finance • 20 days ago
The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: TD Cowen upgraded Paycom (PAYC) to Buy... Full story
Yahoo Finance • last month
As of September 2025, the U.S. stock market is experiencing a mixed performance, with the S&P 500 and Nasdaq reaching new closing highs while the Dow Jones Industrial Average sees a decline ahead of key inflation data releases. In this env... Full story
Yahoo Finance • last month
Company Logo Liquid Biopsy MarketLiquid Biopsy Market Dublin, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The "Liquid Biopsy Market by Product & Service (Kits, Instruments), Circulating Biomarker (ctDNA, cfDNA, CTC), Technology (NGS, PCR), Applic... Full story
Yahoo Finance • last month
On Friday, the District Court for the Middle District of North Carolina issued a ruling invalidating specific claims in two patents that Natera Inc. (NASDAQ:NTRA) asserted against NeoGenomics, Inc.'s (NASDAQ:NEO) v1.1 RaDaR test. Natera s... Full story
Yahoo Finance • last month
Check out the companies making the biggest moves midday: Petco Health & Wellness — The pet store and veterinary services provider surged 22% after raising its full-year adjusted EBITDA guidance. Second-quarter earnings per share topped ana... Full story
Yahoo Finance • last month
[Legal rights concept Statue of Lady Justice holding scales of justice] deepblue4you * NeoGenomics (NASDAQ:NEO [https://seekingalpha.com/symbol/NEO]) shares climbed ~20% in the premarket on Friday after the company announced a major vic... Full story
Yahoo Finance • last month
As of August 2025, the U.S. stock market is experiencing a remarkable upswing, with key indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid anticipation of a significant inflation report. In this thriving e... Full story
Yahoo Finance • 2 months ago
Investing.com - Natera (NASDAQ:NTRA) shares rose after UBS reiterated its Buy rating and $218.00 price target following positive clinical trial results for the company’s Signatera test. Currently trading at $161.94, the stock has shown str... Full story
Yahoo Finance • 2 months ago
AUSTIN, Texas - Natera, Inc. (NASDAQ:NTRA), a diagnostics company with a market capitalization of $22.37 billion and impressive revenue growth of 44% over the last twelve months, announced Monday that a phase III clinical trial using its S... Full story
Yahoo Finance • 2 months ago
John Fesko, President and Chief Business Officer at Natera, Inc. (NASDAQ:NTRA), sold a total of 678 shares of common stock on August 14, 2025, at prices ranging from $155.30 to $155.46, totaling approximately $105,400. The stock, which cur... Full story
Yahoo Finance • 2 months ago
Solomon Moshkevich, President, Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), sold a total of 875 shares of common stock on August 14, 2025. The shares were sold at prices ranging from $155.4248 to $155.46, for a total value of approx... Full story
Yahoo Finance • 2 months ago
Director and co-founder of Natera, Inc. (NASDAQ:NTRA), Sheena Jonathan, reported selling shares of common stock on August 8 and August 11, 2025, for a total value of $958059. The transactions come as the diagnostic testing company’s stock... Full story
Yahoo Finance • 2 months ago
Cathie Wood’s ARK ETFs have made notable moves in the market on Tuesday, 12 August 2025, with a series of buys and sells that signal the investment firm’s strategic adjustments. The most significant transaction of the day involved the sale... Full story
Yahoo Finance • 2 months ago
On Tuesday, 12 August 2025, Natera Inc (NASDAQ:NTRA) participated in Canaccord Genuity’s 45th Annual Growth Conference. The company highlighted its strategic focus on innovation and growth, with positive developments in clinical trials and... Full story
Yahoo Finance • 2 months ago
Below is Validea's guru fundamental report for NATERA INC (NTRA). Of the 22 guru strategies we follow, NTRA rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for... Full story
Yahoo Finance • 2 months ago
Aug 8 - Tesla (TSLA, Financial) and Palantir Technologies (NASDAQ:PLTR) led mega-cap gains on Friday as broader markets advanced, buoyed by AI developments and investor positioning around Federal Reserve leadership shifts, according to a F... Full story
Yahoo Finance • 2 months ago
Check out the companies making headlines in midday trading. Trade Desk — Shares cratered 37% after a slew of Wall Street firms including Bank of America and MoffettNathanson downgraded the stock . While Trade Desk's earnings were surprisin... Full story
Yahoo Finance • 2 months ago
Solomon Moshkevich, President, Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), a $19.2 billion market cap company, sold 3,000 shares of common stock on August 1, 2025, according to a Form 4 filing with the Securities and Exchange Commi... Full story
Yahoo Finance • 2 months ago
In the last week, the market has been flat, but it is up 16% over the past year with earnings forecast to grow by 15% annually. In this context of steady growth, identifying high-growth tech stocks involves looking for companies that are w... Full story
Yahoo Finance • 2 months ago
John Fesko, President and Chief Business Officer at Natera, Inc. (NASDAQ:NTRA), sold 1,710 shares of common stock on July 28, 2025, at a price of $139.8083, for a total value of $239,072. The transaction occurred in a $19.2 billion market... Full story